Clinical Trial

Sodium Bicarbonate in Intra-dialytic Hypertension in Chronic Hemodialysis Patients

Name: Sodium Bicarbonate in Intra-dialytic Hypertension in Chronic Hemodialysis Patients — clinical trial record (NCT07231900)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2/3

View on ClinicalTrials.gov →

Summary

The study is designed to diminish intra-dialytic hypertension in chrnic hemodialysis patients suffering from metabolic acidosis (low bicarbonate levels). The intervention is a tab of 500 mg sodium bicarbonate twice a day for one month, vs. placebo.

Trial Details

NCT Number	NCT07231900
Lead Sponsor	Assaf-Harofeh Medical Center
Conditions	Hypertension in Dialysis Patients
Enrollment	40 participants
Start Date	2025-11-10
Primary Completion	2027-12-01 (estimated)
Study Completion	2027-12-01 (estimated)
Updated on ClinicalTrials.gov	2025-11-17